The observed enhancement in basal UPRER activation in melanoma cells is in part justified by the increased protein synthesis burden required for proliferation, driven by the constitutively activation of the MAPK pathway and AKT, downstream mediators of the RAS–RAF and PI3K pathways, respectively (107). This evidence concerns the gene AKT1 and melanoma.